References
- M. C. Allison, A. G. Howastan, C. J. Torrance, F. D. Lee and R. N. Russell, Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs, Engl. J. Med. 327 (1982) 749-754.
- D. Bohl, H. Gaussmann, G. Vorberg, J. Sanch, R. Garcia-Barbal, J. F. Sarti and F. J. J. Harrison, A clinical trial comparing a new NSAID: Droxicam and proxicam in spinal osteoarthritis, Int. J. Clin. Pharmacol. Ther. Toxic. 28 (1990) 416-419.
- R. S. Shelley and Y. Wei, Solutions of Aryl or Heteroaryl Substituted Alkanoic Acids in Lipophilic Solvents and Soft Gelatin Capsules Containing Such Solutions, Eur. Pat. Pub., 30 Nov. 1995, WO, 9531979, 1994.
- K. Chegaev, L. Lazzarato, P. Tosco, C. Cena, E. Marini, B. Rolando, P. A. Carrupt, R. Fruttero and A. Gasco, NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilatory properties, J. Med. Chem. 50 (2007) 1449-1457; DOI: 10.1021/jm0607247.
- M. Biava, G. C. Porretta, G. Poce, S. Supino, S. Forli, M. Rovini, A. Cappelli, F. Manetti, M. Botta, L. Sautebin, A. Rossi, C. Pergola, C. Ghelardini, E. Vivoli, F. Makovec, P. Anzellotti, P. Patrignani and M. Anzini, Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity, J. Med. Chem. 50 (2007) 5403-5411; DOI: 10.1021/jm0707525.
- J. P. Waldo and R. C. Larock, The synthesis of highly substituted isoxazoles by electrophilic cyclization: An efficient synthesis of valdecoxib, J. Org. Chem. 72 (2007) 9643-9647; DOI: 10.1021/jo701942e.
- J. R. Vane, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nature (New Biol.) 231 (1971) 232-235.
- J. A. Mitchell, P. Akaraseenont, C. Themermann, R. J. Flower, J. R. Vane, Selectivity of non steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase, Proc. Natl. Acd. Sci. USA. 90 (1993) 11693-11697.
- R. Sharma and S. C. Chaturvedi, Development of pharmacophoric models on 5,6-diarylimidaxo-[2,1-b]-thiazole for selective cyclooxygenase-2 inhibitors, Indian J. Pharm. Sci. 66 (2004) 758-772.
- R. Sharma, S. C. Chaturvedi and A. K. Saxena, 3D-QSAR studies on novel terphenyls for selective inhibition of cyclooxygenase-2 enzyme, Indian J. Pharm. Sci. 66 (2004) 758-772.
- F. Clerici and D. Pocar, Synthesis of 2-amino-5-sulfanyl-1,3,4-thiadiazole derivatives and evaluation of their antidepressant and anxiolytic activity, J. Med. Chem. 44 (2001) 931-936; DOI: 10.1021/jm001027w.
- R. J. Kulmacz and W. E. M. Lands, Requirements for hydro peroxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase, Prostaglandins 25 (1983) 531-540.
- Colorimetric COX (ovine) inhibitor screening assay, Catalog No. 760111, Cayman Chemical, Ann Arbor (MI) 2005.
- C. A. Winter, E. A. Risely and G. N. Nuss, Carrageenean-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs, Proc. Soc. Exp. Biol. 111 (1962) 544-547.
- H. G. Vogel, Drug Discovery and Evaluation Pharmacological Assays, Springer, Frankfurt 2002, pp. 694.
- R. R Ranatunge, M. Augustyniak, U. K. Bandarage, R. A. Earl, J. L. Ellis, D. S. Garvey, D. R. Janero, L. G. Letts, A. M. Martino, M. G Murty, S. K. Richardson, J. D. Schroeder, M. J. Shumway, S. W. Tam, A. M. Trocha and D. V. Young, Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor containing pyrazoles, J. Med. Chem. 47 (2004) 2180-2193; DOI: 10.1021/jm0302769.